Skip to main content
. 2009 Jul 8;2009(3):CD006529. doi: 10.1002/14651858.CD006529.pub2

Comparison 4. Remission at acute phase (6‐12 weeks).

Outcome or subgroup title No. of studies No. of participants Statistical method Effect size
1 Milnacipran vs TCAs 4 537 Odds Ratio (M‐H, Random, 95% CI) 0.82 [0.57, 1.19]
1.1 Milnacipran vs Imipramine 3 430 Odds Ratio (M‐H, Random, 95% CI) 0.94 [0.62, 1.41]
1.2 Milnacipran vs Clomipramine 1 107 Odds Ratio (M‐H, Random, 95% CI) 0.43 [0.17, 1.07]
2 Milnacipran vs SSRIs 6 1028 Odds Ratio (M‐H, Random, 95% CI) 0.98 [0.73, 1.32]
2.1 Milnacipran vs Fluvoxamine 1 113 Odds Ratio (M‐H, Random, 95% CI) 1.48 [0.66, 3.30]
2.2 Milnacipran vs Fluoxetine 3 560 Odds Ratio (M‐H, Random, 95% CI) 0.91 [0.56, 1.46]
2.3 Milnacipran vs Paroxetine 1 302 Odds Ratio (M‐H, Random, 95% CI) 0.92 [0.57, 1.49]
2.4 Milnacipran vs Sertraline 1 53 Odds Ratio (M‐H, Random, 95% CI) 0.0 [0.0, 0.0]